Soyasaponin II protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice
2020 · Theranostics · 64 citations
https://doi.org/10.7150/thno.40128
Q
Qifan Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
1.0K
Citations
16
h-index
24
i10-index
Qifan Zhang is an academic researcher from Guangzhou University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatocellular Carcinoma Treatment and Prognosis & Endoplasmic Reticulum Stress and Disease. The author has an h-index of 16, co-authored 55 publications.
ORCID: 0000-0002-1272-3156Papers by this author
worksAdvanced oxidation protein products induce S-phase arrest of hepatocytes via the ROS-dependent, β-catenin-CDK2-mediated pathway
2017 · Redox Biology · 56 citations
https://doi.org/10.1016/j.redox.2017.09.011
ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway
2021 · Cell Death and Disease · 48 citations
https://doi.org/10.1038/s41419-020-03291-2
Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress
2020 · Cell Death and Disease · 40 citations
https://doi.org/10.1038/s41419-019-2214-9
Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1/M2-macrophage infusion on liver recovery after hepatectomy
2021 · Cell Death and Disease · 39 citations
https://doi.org/10.1038/s41419-021-03616-9
A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients
2021 · Frontiers in Oncology · 9 citations
https://doi.org/10.3389/fonc.2021.665497
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat